Effect of Linoleic Acid of Nigella Sativa on MDA-MB-231 Human Breast Cancer Cells

被引:0
|
作者
Hasanzadeh, G. K. [1 ]
Latiffah, A. L. [1 ]
Hanachi, P. [2 ]
Lajis, Hj N. [3 ]
机构
[1] Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Community Hlth, Serdang 43400, Malaysia
[2] Alzahra Univ, Fac Basic Sci, Biol Dept, Tehran, Iran
[3] Univ Putra Malaysia, Inst Biosci, Lab Natl Product, Serdang 43400, Malaysia
关键词
Linoleic acid; Nigella sativa; MDA-MB-231;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Breast cancer is one of the main life-threatening diseases which a woman may face during her life. Several lifestyle factors such as weight gain, obesity, fat intake and decreased level of physical activity are associated with breast cancer risk. In vitro and vivo studies showed that, Linoleic acid (LA) is one of the main fatty acids composition of Nigella sativa. The objective was to investigate inhibitory and anti-cancer effects of Linoleic acid on the MDA-MB-231 human breast cancer cells. Methods: The apoptosis and cytotoxic activity assay was used in order to find toxic effects and the results were supported by flow cytometry (Cell cycle analysis). The results showed the cytotoxic effect of Linoleic acid on the breast cancer cell can be considered as an anti-cancer effect of LA. Results: According to our findings, when the concentration of lionleic acid was increased, compared with the concentrations currently being reported, it showed an anti-cancer effects. The IC50 was 84.72 mu l/ml. There was a significant (p<0.05) effect between the treatment groups which are more than IC 50 and the control group. Conclusion: We came to this conclusion that Linoleic acid has an inhibitory effect on human breast cancer cell lines which can be due to its two double-bandings molecular structure.
引用
收藏
页码:65 / 70
页数:6
相关论文
共 50 条
  • [31] Effect of Curcumin on Cell- ECM Interaction in Human Breast Cancer Cells MDA-MB-231
    Pal, Sekhar
    Ganguly, Kirat Kumar
    Chatterjee, Amitava
    BIOSCIENCE BIOTECHNOLOGY RESEARCH COMMUNICATIONS, 2020, 13 (02): : 516 - 521
  • [32] Development of resistance towards artesunate in MDA-MB-231 human breast cancer cells
    Bachmeier, Beatrice E.
    Killian, Peter H.
    Kronski, Emanuel
    Efferth, Thomas
    CANCER RESEARCH, 2011, 71
  • [33] Pterostilbene Inhibits VEGF Production in Human Breast Cancer [MDA-MB-231] Cells
    Sanghani, Arpitkumar
    Kandra, Theja
    Bavadekar, Supriya
    Vansal, Sandeep
    FASEB JOURNAL, 2013, 27
  • [34] Molecular mechanism underlying the anticancer effect of simvastatin on MDA-MB-231 human breast cancer cells
    Shen, Yuan-Yuan
    Yuan, Yuan
    Du, Ying-Ying
    Pan, Yue-Yin
    MOLECULAR MEDICINE REPORTS, 2015, 12 (01) : 623 - 630
  • [35] Inhibitory Effect of Parthenolide on Human Breast Cancer MDA-MB-231 Cells in Vitro and the Underlying Mechanism
    Xu, Hongjie
    Wei, Dajun
    Gai, Xiaodong
    LATIN AMERICAN JOURNAL OF PHARMACY, 2020, 39 (03): : 570 - 575
  • [36] Atorvastatin induces autophagy in MDA-MB-231 breast cancer cells
    Hu, Ming-Bai
    Zhang, Jing-Wei
    Gao, Jing-Bo
    Qi, Yu-Wen
    Gao, Yang
    Xu, Liu
    Ma, Yanbing
    Wei, Zheng-Zhuan
    ULTRASTRUCTURAL PATHOLOGY, 2018, 42 (05) : 409 - 415
  • [37] Arctigenin Enhances the Cytotoxic Effect of Doxorubicin in MDA-MB-231 Breast Cancer Cells
    Lee, Kyu-Shik
    Lee, Min-Gu
    Kwon, Yun-Suk
    Nam, Kyung-Soo
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (08)
  • [38] Hypoxia regulates stemness of breast cancer MDA-MB-231 cells
    Jing Xie
    Yong Xiao
    Xiao-yan Zhu
    Zhou-yu Ning
    Hai-fan Xu
    Hui-min Wu
    Medical Oncology, 2016, 33
  • [39] Antiproliferative Property and Apoptotic Effect of Xanthorrhizol on MDA-MB-231 Breast Cancer Cells
    Cheah, Yew Hoong
    Nordin, Fariza Juliana
    Tee, Thiam Tsui
    Azimahtol, Hawariah Lope Pihie
    Abdullah, Noor Rain
    Ismail, Zakiah
    ANTICANCER RESEARCH, 2008, 28 (6A) : 3677 - 3689
  • [40] Hypoxia regulates stemness of breast cancer MDA-MB-231 cells
    Xie, Jing
    Xiao, Yong
    Zhu, Xiao-yan
    Ning, Zhou-yu
    Xu, Hai-fan
    Wu, Hui-min
    MEDICAL ONCOLOGY, 2016, 33 (05)